Browse regulations

These Regulations implement sections 39 and 40 of the Competition Act 1998 by defining thresholds below which agreements and conduct are exempt from the Chapter I (anti-competitive agreements) and Chapter II (abuse of dominant position) prohibitions. Small agreements exemption applies to undertakings with combined turnover ≤£20m; conduct of minor significance applies to single undertakings with turnover ≤£50m.

While competition law itself reflects a command-and-control approach that Mises would criticise, these regulations specifically provide relief for small businesses from that burden. Deleting them would harm small British enterprises by subjecting them to full Competition Act compliance costs for conduct unlikely to have significant market impact. The exemption thresholds ensure anti-competitive harm remains possible only for genuinely minor participants, and removing the threshold would eliminate a necessary protection for small UK businesses competing against larger incumbents.

These 2000 Regulations modify procedural provisions of the Competition Act 1998 (Sections 13-16 and Schedule 5) for agreements excluded from the Chapter I prohibition. They establish procedures for businesses to apply for guidance or decisions on whether their agreements would infringe competition rules, and prescribe which decisions are appealable. The modifications add language about 'likely to infringe' and 'would be unlikely to infringe' to account for excluded agreements.

Without procedural regulations governing how businesses seek guidance on competition compliance, there would be no lawful mechanism for obtaining legal certainty. Deletion would create regulatory chaos, leaving businesses unable to determine whether their agreements comply with competition law. The regulations serve a practical administrative function and impose minimal burden - they are merely procedural machinery, not substantive restrictions on agreements themselves.

These 2000 Regulations established the procedural framework for the Immigration and Asylum Act 1999's section 9 regularisation scheme for overstayers, specifying application requirements (personal details, travel history, supporting documents), submission methods (postal or hand-delivery to the Home Office in Croydon), and time limits (regularisation period from 1st February 2000 to 1st October 2000).

These regulations are obsolete — the regularisation period they created ended on 1st October 2000, nearly 26 years ago. The procedural framework they established has no current operative effect. Furthermore, the underlying regularisation scheme itself reflected the inherent contradictions of immigration control: creating the offence of overstaying, then periodically offering amnesty schemes to manage the population that inevitably results from such restrictions. Such schemes perversely incentivise future overstaying by signalling that periodic regularisations may occur, and they distort labour markets by creating a subclass of temporarily tolerated workers. The regulations served a scheme that was itself a band-aid on a wound caused by the state's restriction of voluntary migration.

A 2000 statutory instrument that amends Schedule 4 of the Value Added Tax Act 1994, raising the de minimis threshold for deemed supply of goods from £250 to £1,000. It applies when a person ceases to be a taxable person, exempting small inventories from triggering a VAT liability.

This regulation reduces compliance burden on small businesses by raising the deemed supply threshold. Deleting it would restore the £250 threshold, forcing more small enterprises to account for VAT on remaining inventory when they cease trading—a disproportionate burden for marginal businesses. The amendment achieves its purpose of targeting the deemed supply rule only at commercially significant inventories, avoiding unnecessary compliance costs for small traders.

These Regulations amend the 1996 Health Authorities Regulations to restrict who Health Authorities may contract with for high security psychiatric services. They limit providers exclusively to Ashworth Hospital Authority, Broadmoor Hospital Authority, Rampton Hospital Authority, or Secretary of State-approved NHS trusts. Health Authorities are prohibited by law from arranging such services with any other person or body, including voluntary organisations.

This regulation creates a government-enforced oligopoly restricting competition in high security psychiatric services. By prohibiting Health Authorities from contracting with any other provider, it eliminates market forces that could drive efficiency, innovation, and better patient outcomes. The restriction benefits the three named hospital authorities at the expense of patients and taxpayers. While security considerations may warrant appropriate licensing standards, an absolute prohibition on alternative providers — including voluntary organisations — goes beyond necessary regulation and suppresses supply. This is a classic example of regulatory capture, where incumbent providers use state power to block competition.

This Order established the North Peterborough Primary Care Trust on 17th February 2000 (operational from 1st April 2000), defining its governance structure (5 officer members, 5 non-officer members plus chairman), preparatory period functions (entering NHS contracts and employment contracts), transitional arrangements with Cambridgeshire Health Authority (covering costs) and North West Anglia Health Care NHS Trust (providing premises, facilities and staff), and restrictions on direct patient services.

This regulation is entirely obsolete. Primary Care Trusts were abolished and restructured under the Health and Social Care Act 2012, with further NHS reorganizations rendering this establishment order without legal effect. The specific transitional provisions (preparatory period arrangements, cost-sharing with Cambridgeshire Health Authority and North West Anglia NHS Trust, membership details) are historical artifacts with no current applicability. Retaining this instrument serves no purpose beyond creating statutory clutter and confusion about the current NHS governance framework.

This Order establishes the South Peterborough Primary Care Trust as an NHS body on 17th February 2000 (operational from 1st April 2000). It defines governance structure (5 officer members, 5 non-officer members plus chairman), sets transitional arrangements during the preparatory period, specifies that the Cambridgeshire Health Authority will fund initial costs, and restricts the trust from providing services directly to patients (only community health services permitted). The trust operates under the National Health Service Act 1977 and the Membership Regulations 2000.

This Order perpetuates NHS bureaucratic structures that suppress private healthcare alternatives. Primary Care Trusts were part of the internal market model that added administrative complexity without genuine competition. The restriction preventing direct patient services except community health services codifies the state monopoly on healthcare provision. Deleting this removes one more layer of NHS bureaucracy without causing harm to patients (other NHS structures remain), while supporting the long-term goal of liberalising healthcare markets and enabling private alternatives to compete. The preparatory period costs are also met by taxpayers with no corresponding benefit to healthcare quality.

This Order establishes the Tendring Primary Care Trust as a legal entity effective 17th February 2000, with an operational date of 1st April 2000. It defines governance structure (5 officer members, 5 non-officer members plus chairman), references the National Health Service Act 1977, and specifies that during the preparatory period the trust may only enter contracts and take limited preparatory actions. The North Essex Health Authority funds the trust during its preparatory period. The trust is prohibited from providing services directly to patients, other than community health services, reflecting its role as a commissioning rather than providing body.

This Order is obsolete - Primary Care Trusts were abolished in England in 2013 under the Health and Social Care Act 2012 and no longer exist. Even when operative, PCTs exemplified the NHS's commission-provider split that suppressed private healthcare alternatives, restricted supply of providers, and contributed to Britain's notorious wait times by creating bureaucratic gatekeepers rather than enabling patient choice and market competition in healthcare services.

This Order establishes the Fenland Primary Care Trust as a legal entity, defining its name, area, membership structure (5 officer and 5 non-officer members plus chairman), operational date (1 April 2000), preparatory period functions, and funding arrangements during setup. It also limits the trust from providing services directly to patients other than community health services.

This Order is entirely obsolete. Primary Care Trusts were largely abolished by the Health and Social Care Act 2012, with their functions transferred to Clinical Commissioning Groups and later to Integrated Care Systems. This Order merely establishes a specific administrative structure for a PCT that has not existed in its original form for over a decade. As organizational law for a defunct NHS body, it serves no current purpose and creates unnecessary legislative clutter on the statute books. No Britons would be worse off by its deletion as the entity it created no longer exists.

Establishes the Epping Forest Primary Care Trust as a NHS body under the National Health Service Act 1977, setting out its name, area coverage, membership structure (chairman plus 5 officer and 5 non-officer members), operational date (1 April 2000), preparatory period arrangements, cost-sharing with North Essex Health Authority, and resource-sharing with Essex and Herts Community NHS Trust. The order restricts the trust from providing services directly to patients other than community health services.

This order establishes yet another layer of NHS bureaucracy that entrenches the public monopoly over healthcare provision. Primary Care Trusts were instruments of the state-controlled NHS model that suppressed private healthcare alternatives, restricted supply of providers, and perpetuated wait times that would be scandalic in a liberalized market. The restriction preventing the trust from providing services directly to patients (other than community health services) codifies the very NIMBYism regarding private alternatives that has kept British healthcare uncompetitive. While this is a local administrative order, it exemplifies the institutional framework that has made the UK healthcare sector among the least dynamic in the developed world.

Amends the Special Commissioners (Jurisdiction and Procedure) Regulations 1994 to extend the Special Commissioners' jurisdiction to cover appeals under stamp duty enactments (Stamp Act 1891 s.13(4) and Finance Act 1999 Schedule 17 Part II), and provides that penalties determined by the Tribunal in such proceedings are treated as penalties due under those enactments.

This is a procedural regulation clarifying appeal jurisdiction and penalty treatment for an existing tax tribunal. While stamp duty itself is a distortionary transaction tax, these Regulations merely establish how disputes are handled—not whether stamp duty should exist. Deleting them would create procedural gaps in dispute resolution without reducing the actual regulatory burden of the underlying tax. The amendment is narrow and administrative, treating stamp duty penalties equivalently to other tax penalties already within the tribunal's purview.

These regulations permit the use of a Welsh language version of the prescribed form for Enduring Powers of Attorney, as an alternative to the English language form set out in the 1990 Regulations. They came into force on 1st March 2000.

This regulation imposes no burden - it is purely facilitative, providing an optional Welsh language form that volitional use. Deleting it would remove a valuable option for Welsh-speaking citizens engaging in important financial and legal planning, potentially excluding them from equally accessible legal documentation in their preferred language. It does not restrict trade, impose compliance costs, or distort market incentives.

These are the Consumer Credit (Credit Reference Agency) Regulations 2000, which revoke the 1977 Regulations and prescribe: (1) a seven working day period for credit reference agencies to respond to requests under sections 157(1), 158(1) and 160(3) of the Consumer Credit Act 1974; (2) prescribed forms in Schedules 2 and 3 for requests under sections 158(2) and 160(3); and (3) the manner in which applications under section 159(5) by objectors, business consumers, and agencies shall be made to the relevant authority, including required contents and documentation.

This regulation imposes arbitrary bureaucratic requirements that the market would handle better. The mandatory 7-day response period, prescribed government forms, and detailed application procedures for objections add compliance costs without corresponding benefit — credit reference agencies already have strong commercial incentives to respond promptly and maintain accurate records. These procedural requirements reflect the paternalistic assumption that without government mandates, agencies would behave irresponsibly. The forms and documentation requirements (copies of files, correspondence, and other documents) impose administrative burden that raises costs for agencies and ultimately consumers. Competition and contractual relationships would naturally produce appropriate service standards. This is precisely the type of micro-regulatory intervention that Friedman and Hayek warned distorts incentives and creates unnecessary compliance overhead.

Amends the Consumer Credit (Conduct of Business) (Credit References) Regulations 1977 to require credit reference agencies to notify all persons to whom they have furnished relevant financial information within 10 working days when: entries are removed/amended, notices of correction are added, or compliance periods expire. Defines 'relevant date' as six months before an individual's data access request.

Imposes ongoing administrative notification burdens on credit reference agencies with no clear corresponding benefit — if an individual corrects their file, recipients notified years ago may have already used the information and taken action. The 10-working-day强制通知 requirement to all parties who received information in the preceding 6 months is clumsy, costly to administer, and of questionable value in improving credit market efficiency. In the modern data environment, parties receiving credit information can maintain their own records and re-query as needed. Such notification requirements add compliance costs that could make UK credit reference agencies less competitive relative to equivalent services in New York, Singapore, or Dubai.

These 2000 Amendment Regulations to the 1994 Medicines for Human Use Regulations: (1) updated references to EU pharmaceutical directives with phased application dates; (2) inserted new regulation 3A establishing a detailed administrative procedure for determining whether 'borderline products' constitute 'relevant medicinal products' requiring marketing authorization, including provisional determination notices, written/oral representation rights, review panel hearings, and enforcement powers to halt marketing; (3) added corresponding criminal offences for non-compliance; and (4) made minor technical word substitutions.

Regulation 3A creates an elaborate bureaucratic regime for classifying borderline products as medicinal products requiring marketing authorization. This process—with its provisional determinations, review panels, written/oral representations, and appeal procedures—imposes substantial compliance costs that function as barriers to market entry, particularly for small producers and innovative products. Such authorization requirements historically serve incumbent protection rather than genuine public health improvement; the safety objectives can be achieved through simpler, less restrictive means such as adverse event reporting systems or product liability rules. Post-Brexit regulatory independence offers the opportunity to replace this inherited EU-derived procedure with a more proportionate framework that does not require prior government permission to market products.